Trials that use: Wald / z-test
1,534 results
- A Digital Intervention to Prevent the Initiation of Opioid Misuse in Adolescents in School-based Health Centers: Complete Statistical AnalysisIndependent statistical analysis of A Digital Intervention to Prevent the Initiation of Opioid Misuse in Adolescents in School-based Health Centers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Dose Proportionality Study of Quinine Sulfate Capsules Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of A Dose Proportionality Study of Quinine Sulfate Capsules Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Dose-finding Study of OPC-6535 in Patients With Active Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02431052).
- A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment: Complete Statistical AnalysisIndependent statistical analysis of A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Double Blind Clinical Trial of DCS for Food Anxiety: Complete Statistical AnalysisIndependent statistical analysis of A Double Blind Clinical Trial of DCS for Food Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01996644).
- A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients…
- A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea: Complete Statistical AnalysisIndependent statistical analysis of A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea:…
- A Home-based Training Program for Elderly Patients With Dementia: Complete Statistical AnalysisIndependent statistical analysis of A Home-based Training Program for Elderly Patients With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02667951).
- A Mobile Phone Based Pilot Intervention to Prevent Obesity in Latino Preschool Children: Complete Statistical AnalysisIndependent statistical analysis of A Mobile Phone Based Pilot Intervention to Prevent Obesity in Latino Preschool Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease: Complete Statistical AnalysisIndependent statistical analysis of A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease: primary endpoint results,…
- A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine: Complete Statistical AnalysisIndependent statistical analysis of A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02025556).
- A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia: Complete Statistical AnalysisIndependent statistical analysis of A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia: primary endpoint results, effect estimate with confidence…
- A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations: Complete Statistical AnalysisIndependent statistical analysis of A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations: primary endpoint…
- A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01742091).
- A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002): Complete Statistical AnalysisIndependent statistical analysis of A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate…
- A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma: Complete Statistical AnalysisIndependent statistical analysis of A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache: Complete Statistical AnalysisIndependent statistical analysis of A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01899040).
- A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval,…
- A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01702519).
- A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01626859).
- A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris: primary endpoint results, effect estimate with confidence…
- A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy: primary endpoint…
- A Phase 2 Study For Patients With A Physician’s Diagnosis Of Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren’s Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome: primary endpoint results, effect estimate with confidence interval,…
- A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1…
- A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1): Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1): primary endpoint results, effect estimate…
- A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson’s Disease Patients: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine): Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic…
- A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome: primary endpoint results, effect estimate…
- A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2…
- A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma: primary…
- A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Phase II Trial of Regadenoson in Sickle Cell Anemia: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Trial of Regadenoson in Sickle Cell Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01788631).
- A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150): Complete Statistical AnalysisIndependent statistical analysis of A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients: Complete Statistical AnalysisIndependent statistical analysis of A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor: Complete Statistical AnalysisIndependent statistical analysis of A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor: primary endpoint results,…